Adial Pharmaceuticals, Inc. WT EXP 073123 (ADILW) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The current CEO is None.
ADILW has IPO date of 2018-07-27, listed on the NASDAQ Capital Marke.
No company description available.
